ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 118140
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 56111
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 50156
 
  
 
C07K PEPTIDES 4195
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3887
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 3762
 
  
 
C07D HETEROCYCLIC COMPOUNDS 26136
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1976
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1287
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 9231

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0074,049 METHODS AND COMPOSITIONS FOR RAPID FUNCTIONAL ANALYSIS OF GENE VARIANTSNov 21, 17Mar 15, 18[G01N]
2018/0055,877 THERAPEUTIC NANOPARTICLES AND METHODS THEREOFOct 05, 17Mar 01, 18[A61J, A61K]
2017/0332,910 MODIFIED PARAMAGNETIC NANOPARTICLES FOR TARGETED DELIVERY OF THERAPEUTICS AND METHODS THEREOFNov 02, 15Nov 23, 17[A61K, A61B, G01R]
2017/0335,406 METASTASIS SPECIFIC SPLICE VARIANTS OF MENA AND USES THEREOF IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMORSJul 27, 17Nov 23, 17[A61K, C12Q, G01N]
2017/0304,200 PROGRAMMED CARGO RELEASE USING NUCLEIC ACID-STABILIZED MICELLESOct 07, 15Oct 26, 17[A61K]
2017/0299,600 METHODS AND COMPOSITIONS FOR ASSESSING GERMLINE RISK OF CANCERAug 19, 15Oct 19, 17[C12Q, G01N]
2017/0277,766 SEMANTIC INDEXING ENGINEJun 10, 17Sep 28, 17[G06F]
2017/0246,215 REPOPULATION OF ORGANS AND TISSUES USING A YAP-ERT2 FUSION PROTEINSep 11, 15Aug 31, 17[A61K]
2017/0128,416 ORAL ADMINISTRATION OF MELANIN FOR PROTECTION AGAINST RADIATIONAug 08, 16May 11, 17[A61K]
2017/0114,100 TARGETING DIMERIZATION OF BAX TO MODULATE BAX ACTIVITYMay 28, 15Apr 27, 17[G01N, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920102 Fusion tags for protein expressionMay 12, 16Mar 20, 18[C12N, C07K]
9914926 Fidgetin-like 2 as a target to enhance wound healingMar 01, 16Mar 13, 18[A61K, C12N]
9907982 Method of diagnosis and treatment of tumors using high intensity focused ultrasoundSep 29, 16Mar 06, 18[A61B, A61N]
9890143 Retinoic acid receptor antagonists as chaperone-mediated authophagy modulators and uses thereofOct 20, 16Feb 13, 18[C07D, C07C]
9880173 Pyrite shrink-film laminate as a hydroxyl radical generatorDec 28, 15Jan 30, 18[G01N]
9873918 Treatment of acute myeloid leukemia and myelodysplastic syndromesAug 09, 12Jan 23, 18[A61K, C12Q, G01N, C07K]
9857378 Tuberculosis biomarkers and uses thereofAug 26, 15Jan 02, 18[A61K, G01N]
9841424 Serologic test for the rapid diagnosis of active tuberculosisOct 10, 13Dec 12, 17[G01N]
9809560 Ligands and methods for labeling biomolecules in vivoAug 05, 11Nov 07, 17[A61K, C07D, G01N]
9782441 Stromal cell therapy in treatment of radiation injuryJul 10, 12Oct 10, 17[A61K, A01N, C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0119,814 THERAPEUTIC NANOPARTICLES AND METHODS THEREOFAbandonedJun 11, 15May 04, 17[A61J, A61K]
2016/0356,779 METHODS OF GRADING CARCINOMASAbandonedFeb 09, 15Dec 08, 16[A61K, G01N]
2016/0298,165 METHOD OF TREATING TUBERCULOSISAbandonedApr 25, 14Oct 13, 16[A61K, C12Q, G01N]
2016/0075,768 ADJUVANT THERAPY FOR STAPHYLOCOCCAL INFECTION WITH ENTEROTOXIN SPECIFIC MABSAbandonedNov 11, 15Mar 17, 16[C07K]
2016/0039,914 HUMANIZED ANTIBODIES SPECIFIC FOR STAPHYLOCOCCAL ENTEROTOXIN BAbandonedMar 13, 14Feb 11, 16[A61K, C07K]
2016/0032,383 PANEL OF microRNA BIOMARKERS IN HEALTHY AGINGAbandonedMar 14, 14Feb 04, 16[A61K, C12Q]
2016/0024,042 Prodrugs of Fluorinated Mevalonates to Inhibit the Mevalonate Pathway of Streptococcus pneumoniaeAbandonedOct 06, 15Jan 28, 16[C07D, C07C]
2015/0359,815 PAK1 INHIBITION FOR TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMESAbandonedSep 04, 15Dec 17, 15[A61K, C12Q]
2015/0313,935 ENHANCED NITRIC OXIDE DELIVERY AND USES THEREOFAbandonedJul 15, 15Nov 05, 15[A61K]
2015/0299,336 THERAPEUTIC AND DIAGNOSTIC TARGET GENE IN ACUTE MYELOID LEUKEMIAAbandonedMar 26, 15Oct 22, 15[C12N, C07K]
2015/0224,188 USE OF MEMBRANE VESICLE-BASED VACCINE AGAINST M. TUBERCULOSISAbandonedSep 23, 13Aug 13, 15[A61K]
2014/0370,027 INHIBITION OF MACROPHAGE-SYNTHESIZED WNT7B TO INHIBIT TUMOR ANGIOGENESIS AND METASTASISAbandonedMar 30, 12Dec 18, 14[A61K, C12N, G01N, C07K]
2014/0363,407 NEURAL STEM CELL THERAPY FOR OBESITY AND DIABETESAbandonedJan 23, 13Dec 11, 14[A61K, C12Q]
2014/0363,493 LIPID NANOPARTICLES FOR TARGETED siRNA DELIVERYAbandonedJun 09, 14Dec 11, 14[A61K]
2014/0329,692 METHOD FOR MEASURING DNA METHYLATION PROFILESAbandonedApr 16, 14Nov 06, 14[C12Q, G01N]
2014/0329,714 STAT3 ACTIVATION AS A MARKER FOR CLASSIFICATION AND PROGNOSIS OF DLBCL PATIENTSAbandonedNov 28, 12Nov 06, 14[C12Q]
2014/0329,766 Prophylactic Compositions for Management of Microbial Infections in Patients with Brain InjuryAbandonedNov 28, 12Nov 06, 14[A61K]
2014/0322,242 MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF CANCERAbandonedNov 24, 11Oct 30, 14[A61K, C12Q, G01N, C07K]
2014/0314,790 CASPASE 9 INHIBITION AND BRI2 PEPTIDES FOR TREATING DEMENTIAAbandonedOct 02, 12Oct 23, 14[A61K, C12N, C07K]
2014/0302,050 TARGETING AN AMPHIREGULIN-DERIVED CELL SURFACE NEO-EPITOPEAbandonedOct 24, 12Oct 09, 14[A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.